» Articles » PMID: 24523238

Human Platelet MicroRNA-mRNA Networks Associated with Age and Gender Revealed by Integrated Plateletomics

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2014 Feb 14
PMID 24523238
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

There is little data considering relationships among human RNA, demographic variables, and primary human cell physiology. The platelet RNA and expression-1 study measured platelet aggregation to arachidonic acid, ADP, protease-activated receptor (PAR) 1 activation peptide (PAR1-AP), and PAR4-AP, as well as mRNA and microRNA (miRNA) levels in platelets from 84 white and 70 black healthy subjects. A total of 5911 uniquely mapped mRNAs and 181 miRNAs were commonly expressed and validated in a separate cohort. One hundred twenty-nine mRNAs and 15 miRNAs were differentially expressed (DE) by age, and targets of these miRNAs were over-represented among these mRNAs. Fifty-four mRNAs and 9 miRNAs were DE by gender. Networks of miRNAs targeting mRNAs, both DE by age and gender, were identified. The inverse relationship in these RNA pairs suggests miRNAs regulate mRNA levels on aging and between genders. A simple, interactive public web tool (www.plateletomics.com) was developed that permits queries of RNA levels and associations among RNA, platelet aggregation and demographic variables. Access to these data will facilitate discovery of mechanisms of miRNA regulation of gene expression. These results provide new insights into aging and gender, and future platelet RNA association studies must account for age and gender.

Citing Articles

Argonaute2 modulates megakaryocyte development and sex-specific control of platelet protein expression and reactivity.

Lazar S, Wurtzel J, Askari S, Cooper M, Zhao X, Ma P Sci Rep. 2025; 15(1):3590.

PMID: 39875491 PMC: 11775343. DOI: 10.1038/s41598-025-88106-0.


Demographic diversity in platelet function and response to antiplatelet therapy.

Jain K, Tyagi T, Gu S, Faustino E, Hwa J Trends Pharmacol Sci. 2024; 46(1):78-93.

PMID: 39672782 PMC: 11710996. DOI: 10.1016/j.tips.2024.11.005.


MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances.

Metcalf G Oncogene. 2024; 43(28):2135-2142.

PMID: 38839942 PMC: 11226400. DOI: 10.1038/s41388-024-03076-3.


Heterogeneity of platelets and their responses.

Thomas S, Kelliher S, Krishnan A Res Pract Thromb Haemost. 2024; 8(2):102356.

PMID: 38666061 PMC: 11043642. DOI: 10.1016/j.rpth.2024.102356.


Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y Inhibitors and Their Association with Platelet Function.

Gumiezna K, Bednarek A, Sygitowicz G, Maciejak-Jastrzebska A, Barus P, Hunia J J Clin Med. 2024; 13(1).

PMID: 38202070 PMC: 10780110. DOI: 10.3390/jcm13010063.


References
1.
Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

2.
Denis M, Tolley N, Bunting M, Schwertz H, Jiang H, Lindemann S . Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005; 122(3):379-91. PMC: 4401993. DOI: 10.1016/j.cell.2005.06.015. View

3.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

4.
Gee J, Ding Q, Keller J . Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain. Biogerontology. 2006; 7(2):69-79. DOI: 10.1007/s10522-005-6039-9. View

5.
Wren J, Bateman A . Databases, data tombs and dust in the wind. Bioinformatics. 2008; 24(19):2127-8. DOI: 10.1093/bioinformatics/btn464. View